OXR1基因治疗延缓rd1视网膜变性小鼠模型中的神经退行性变
本研究探讨人OXR1(hOXR1)抗氧化调节基因能否保护神经元免受氧化应激并延迟光感受器细胞死亡。在661W细胞系中过表达hOXR1可增加细胞对H2O2诱导氧化应激的抵抗、降低ROS水平和caspase切割;在rd1小鼠中视网膜下注射AAV8-hOXR1改善了光感受器光反应并延迟视网膜变性。结果表明OXR1是视网膜变性的潜在治疗候选。
要点
- hOXR1在661W细胞中降低ROS和caspase切割,增强抗氧化应激能力。
- rd1小鼠视网膜下注射AAV8-hOXR1改善光感受器功能并延迟变性。
- OXR1靶向氧化应激,可能对多种视网膜退行性疾病有治疗价值。
核心结论
- OXR1是视网膜变性的潜在治疗候选,因其靶向多种视网膜退行性疾病共有的氧化应激特征。
研究设计与样本
- 体外使用稳定表达hOXR1的661W细胞系,用H2O2诱导氧化应激。
- 体内将AAV8-hOXR1视网膜下注射至rd1视网膜变性小鼠模型。
主要发现
- hOXR1表达增加661W细胞对H2O2诱导氧化应激的抵抗,降低ROS水平和caspase切割。
- rd1小鼠视网膜下注射AAV8-hOXR1改善光感受器光反应及光感受器特异性蛋白的表达和定位,并延迟视网膜变性。
临床怎么用
- OXR1基因治疗可能作为延缓视网膜变性的策略,但尚未进入临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oxidative stress is a major factor underlying many neurodegenerative diseases. However, antioxidant therapy has had mixed results, possibly because of its indiscriminate activity. The purpose of our study was to determine if the human OXR1 (hOXR1) antioxidant regulatory gene could protect neurons from oxidative stress and delay photoreceptor cell death. METHODS: The cone-like 661W cell line was transfected to stably express the hOXR1 gene. Oxidative stress was induced by the addition of hydrogen peroxide (H2O2). Intracellular levels of reactive oxygen species (ROS), caspase cleavage, and cellular resistance to oxidative stress were determined and compared between the control and hOXR1 cells. For in vivo analysis, AAV8-hOXR1 was injected subretinally into the rd1 mouse model of retinal degeneration. Functional and structural integrity of the photoreceptors were assessed using electroretinography (ERG), histology, and immunofluorescence analysis. RESULTS: Expression of hOXR1 increased cellular resistance and reduced ROS levels and caspase cleavage in the 661W cell line after H2O2-induced oxidative stress. Subretinal injection of AAV8-hOXR1 in the rd1 mice improved their photoreceptor light response, expression and localization of photoreceptor-specific proteins, and delayed retinal degeneration. CONCLUSIONS: Our results suggest that OXR1 is a potential therapy candidate for retinal degeneration. Because OXR1 targets oxidative stress, a common feature of many retinal degenerative diseases, it should be of therapeutic value to multiple retinal degenerative diseases.
引用
- Sahu B, Leon LM, Zhang W, et al. Oxidative Stress Resistance 1 Gene Therapy Retards Neurodegeneration in the rd1 Mutant Mouse Model of Retinopathy. Invest Ophthalmol Vis Sci. 2021. PMID: 34505865. doi:10.1167/iovs.62.12.8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。